Recently, I spoke with a chief product officer at a large excess and surplus (E&S) company, and he shared his vision for streamlining intake in this way: “Straight-through processing a third, decline a third, and send the rest to underwriting.”

But adopting that kind of intake strategy naturally leads to a deeper question: How does an insurance company decide what deserves underwriting consideration in the first place?